Organoselenium Compounds in Medicinal Chemistry
ChemMedChem · 02.09.2024 · 19 (17)
DOI: 10.1002/cmdc.202400063 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemMedChem, online erschienen am 12.07.2024. Verfasst von Carola Gallo-Rodriguez und 1 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química Orgánica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Pabellón 2, C1428EHA, …. Hauptthemen laut MEDLINE: Organoselenium Compounds. Die Arbeit wurde bisher 115-mal zitiert (Crossref) und nennt 311 Literaturangaben. Gefördert von: Consejo Nacional de Investigaciones Científicas y Técnicas, Agencia Nacional de Promoción Científica y Tecnológica, Universidad de Buenos Aires.
Abstract (Originalsprache)
The chemical and biological interest in this element and the molecules bearing selenium has been exponentially growing over the years. Selenium, formerly designated as a toxin, becomes a vital trace element for life that appears as selenocysteine and its dimeric form, selenocystine, in the active sites of selenoproteins, which catalyze a wide variety of reactions, including the detoxification of reactive oxygen species and modulation of redox activities. From the point of view of drug developments, organoselenium drugs are isosteres of sulfur‐containing and oxygen‐containing drugs with the advantage that the presence of the selenium atom confers antioxidant properties and high lipophilicity, which would increase cell membrane permeation leading to better oral bioavailability. This statement is the paramount relevance considering the big number of clinically employed compounds bearing sulfur or oxygen atoms in their structures including nucleosides and carbohydrates. Thus, in this article we have focused on the relevant features of the application of selenium in medicinal chemistry. With the increasing interest in selenium chemistry, we have attempted to highlight the most significant published data on this subject, mainly concentrating the analysis on the last years. In consequence, the recent advances of relevant pharmacological organoselenium compounds are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Química Orgánica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Pabellón 2, C1428EHA, Buenos Aires, Argentina.
- CONICET-Universidad de Buenos Aires, Centro de Investigaciones en Hidratos de Carbono (CIHIDECAR), C1428EHA, Buenos Aires, Argentina.
- CONICET-Universidad de Buenos Aires, Unidad de Microanálisis y Métodos Físicos en Química Orgánica (UMYMFOR), C1428EHA, Buenos, Aires, Argentina.
ORCID-Profile: Carola Gallo-Rodriguez, Juan B Rodriguez
Förderung
- Consejo Nacional de Investigaciones Científicas y Técnicas
- Agencia Nacional de Promoción Científica y Tecnológica
- Universidad de Buenos Aires
Zitieren
APA
Gallo-Rodriguez, C., & Rodriguez, J. B. (2024). Organoselenium Compounds in Medicinal Chemistry. ChemMedChem, 19(17). https://doi.org/10.1002/cmdc.202400063
Vancouver
Gallo-Rodriguez C, Rodriguez JB. Organoselenium Compounds in Medicinal Chemistry. ChemMedChem. 2024;19(17). doi:10.1002/cmdc.202400063
BibTeX
@article{GalloRodriguez2024,
author = {Gallo-Rodriguez, Carola and Rodriguez, Juan B},
title = {Organoselenium Compounds in Medicinal Chemistry},
journal = {ChemMedChem},
year = {2024},
volume = {19},
number = {17},
doi = {10.1002/cmdc.202400063}
}
EUVIMED